Scleroderma Lung: Pathogenesis, Evaluation and Current Therapy

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.7, 2007-01, pp. : 985-996

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammatory Bowel Disease: Etiology, Pathogenesis and Current Therapy

Current Pharmaceutical Design, Vol. 20, Iss. 7, 2014-02 ,pp. : 1082-1096

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapy in the treatment of scleroderma

By Wigley F.M. Sule S.D.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 1, 2001-01 ,pp. : 31-48

Informa Healthcare

Access to resources Recommend Favorite

Interstitial Lung Damage Due to Cocaine Abuse: Pathogenesis, Pharmacogenomics and Therapy

Current Medicinal Chemistry, Vol. 19, Iss. 33, 2012-11 ,pp. : 5607-5611

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclophosphamide for scleroderma interstitial lung disease

By Antoniu Sabina A

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 393-395

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Hot Topic: Rheumatoid Arthritis: Current Advances in Pathogenesis, Diagnosis and Therapy)

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 6, 2013-03 ,pp. : 697-697

Bentham Science Publishers

Access to resources Recommend Favorite